CEP Competitors

Deploying technology that makes 'Power without Pollution' a reality. Safe, reliable power that doesn't compromise the environment: It's been our mission since the beginning. Clean Energy Systems has successfully transitioned proven and reliable rocket engine combustion principles into a flexible and economically attractive energy generation system for our planet. CES technology enables cleaner and more efficient co-generation of power, steam, water, and CO2 and offers the world a new perspective on the way we assess the value of natural resources. Our core competence allows us to precision engineer complex and intricate technology solutions that meet your needs, be it in combustion, partial combustion, heat transfer, or other applications. Among others, it enables us to precisely control the conversion of a wide variety of fuels with oxygen in oxy-combustion processes. Oxy-fuel combustion generates a drive gas composed of predominantly steam and CO2. This uniquely efficient process allows our customers to profitably utilize fuels that would otherwise be marginal or uneconomic for commercial energy generation. Facilitated through partnerships with our customers and shareholders and enabled by an exceptional research and demonstration facility, CES has developed and built a unique product portfolio. Centered around customized precision-engineered components, our portfolio encompasses 20 to 200 MW steam and CO2 generators, drive gas reheaters, steam/water separators, pressurized heat recovery systems, 30 to 150 MWe expander turbines, and more. These solutions are ready to fulfill our customers' needs for zero emissions power, enhanced oil recovery, and the expansion of natural resource assets.

NexGenSolutions is a certified Autodesk reseller, certified Autodesk Learning Center, and recognized as a top Service Delivery Partner three years running. NexGen technical experts have experience in the industries they serve, with backgrounds in the tool, mold, die, production and prototype CNC machining industry. NexGenSolutions offers a range of training classes, with both beginner and expert-level training classes to get your team up to speed. Our Platinum Support plan ensures your team remains operational with priority customer support, post-processor edits, access to our LMS, and much more.

HepTech began in the life and body of its founder, Todd Schneider, who was born a hemophiliac. He was infected with Hepatitis C and Hepatitis B virus at 2 years old from a blood transfusion, but he did not find out that he was infected until age 30. By then, he had already developed cirrhosis. He had been taking supplements at that time of diagnosis, but the doctors were unfamiliar with their effect, and told him to stop. His health immediately declined, and got even worse when he was given Interferon. It was clear that his life would be short if he followed the medical recommendations, so he started doing his own research. In his search for a personal cure, he talked with doctors and patients -- anyone who claimed to have a cure for Hep C. But, before he took them seriously, he asked to see their laboratory results. Every claim of cure and every test of a new remedy, showed that virus was still present. So, he changed his strategy, and began to ask, "How can the disease be managed? He continued his study of the scientific literature and contacted the people who had done the research. This led him to Dr. Peter Schmid, MD, PhD, a doctor, researcher, inventor who has devoted much of his life to the study of liver health and Hepatitis C. Dr. Schmid developed a protocol to counteract the HCV- induced damage by controlling the inflammation caused the HCV infection. His goal was to stop the inflammation, that lead to cell death and fibrosis. This would allow the liver to then use its regenerative capability to restore liver function. His protocol includes phytochemicals, vitamins, minerals, and amino acids to produce the anti-inflammatory effects. We put his theory to the test by recommending it to a cohort of patients with Hepatitis C. The results were positive; in fact, some of the stories of recovery were near-miraculous. The level of anecdotal response was so strong that we contracted with Dr. Lorne Tyrrell, a world renown researcher at the University of Alberta, to conduct an animal study to see how the liver ...